Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Leading the latest haul is Kimberly-Clark Corp., which has agreed to buy struggling Tylenol maker Kenvue Inc. for roughly $40 ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Kimberly-Clark is buying Tylenol maker Kenvue for nearly $50 billion. Wall Street isn’t too fond of the deal—for good reason.

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...